GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system
2009 ◽
Vol 46
(2)
◽
pp. 123-130
1999 ◽
Vol 58
(7)
◽
pp. 1097-1107
◽
2021 ◽
2013 ◽
Vol 9
(5)
◽
pp. 472-479
◽